BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

79 hedge funds and large institutions have $42M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

less capital invested

Capital invested by funds: $ → $

54% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 24

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$31K
Puts
$40K
Net Calls
Net Calls Change

Top Buyers

1
+$1.78M
2
+$1.78M
3
+$984K
4
Goldman Sachs
Goldman Sachs
New York
+$882K
5
Jane Street
Jane Street
New York
+$411K

Top Sellers

1
-$2.73M
2
-$2.55M
3
-$1.61M
4
State Street
State Street
Massachusetts
-$1.14M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$601K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$1K
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
97
–
98
–
99
–
1 2 3
4